Systematic Financial Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Systematic Financial Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-122,190	Closed	-$1.44M	–	688
2017 Q3	$1.44M	Sell	122,190 -34,770	-22%	-$390K	0.03%	462
2017 Q2	$1.65M	Buy	+156,960	New	+$1.6M	0.03%	474
2016 Q2	–	Sell	-126,290	Closed	-$1.38M	–	668
2016 Q1	$1.38M	Buy	126,290 +24,545	+24%	+$310K	0.02%	488
2015 Q4	$1.76M	Buy	101,745 +15,590	+18%	+$280K	0.02%	390
2015 Q3	$1.71M	Sell	86,155 -64,780	-43%	-$1.49M	0.02%	553
2015 Q2	$2.48M	Buy	+150,935	New	+$2.62M	0.02%	471

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Systematic Financial Management's SCMP Position: Q4 2017 in Review

Systematic Financial Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2017, closing a stake of 122,190 shares — an estimated $1.44M sold.

Systematic Financial Management first reported a position in SCMP in Q2 2015 and held it in 6 quarters. The position peaked at $2.48M in Q2 2015. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

Systematic Financial Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Systematic Financial Management sold 122,190 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $1.44M.
Systematic Financial Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2015 and held it in 6 quarters.
Systematic Financial Management's Sucampo Pharmaceuticals, Inc. position peaked at $2.48M in Q2 2015.
188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on Systematic Financial Management's 13F filing for Q4 2017, filed 9 Feb 2018.